Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PAC-1 by Vanquish Oncology for Solid Tumor: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
PAC-1 by Vanquish Oncology for Solid Tumor: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
PAC-1 by Vanquish Oncology for Pancreatic Endocrine Tumor: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Pancreatic Endocrine Tumor. According to GlobalData,...
PAC-1 by Vanquish Oncology for Neuroendocrine Tumors: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Neuroendocrine Tumors. According to GlobalData, Phase...
PAC-1 by Vanquish Oncology for Lymphoma: Likelihood of Approval
PAC-1 is under clinical development by Vanquish Oncology and currently in Phase I for Lymphoma. According to GlobalData, Phase I...